{"entity":{"type":"insider","cik":"0001714949","url":"/insider/0001714949","json_url":"/insider/0001714949.json","name":"Gray Nancy Ryan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2024-05-17","last":"2025-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Gray Nancy Ryan","source":"filing","n_filings":2,"first_seen":"2024-05-17","last_seen":"2025-11-12"}],"transactions":[{"id":4563586,"accession":"0002001011-25-000098","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002001011-25-000098","line_url":"/filing/0002001011-25-000098#line-4","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001714949","owner_name":"Gray Nancy Ryan","owner_url":"/insider/0001714949","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3556.0,"shares_display":"3,556","price_per_share":205.45,"price_display":"205.45","price_state":"stated","total_value":730580.2,"total_display":"730,580.20","shares_owned_after":8094.0,"shares_owned_after_display":"8,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-12","scope":"insider"},{"id":4563580,"accession":"0002001011-25-000098","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002001011-25-000098","line_url":"/filing/0002001011-25-000098#line-3","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001714949","owner_name":"Gray Nancy Ryan","owner_url":"/insider/0001714949","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3015.0,"shares_display":"3,015","price_per_share":205.45,"price_display":"205.45","price_state":"stated","total_value":619431.75,"total_display":"619,431.75","shares_owned_after":8094.0,"shares_owned_after_display":"8,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-12","scope":"insider"},{"id":2977735,"accession":"0002001011-24-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-24-000054","line_url":"/filing/0002001011-24-000054#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001714949","owner_name":"Gray Nancy Ryan","owner_url":"/insider/0001714949","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":934.0,"shares_display":"934","price_per_share":83.2049,"price_display":"83.20","price_state":"stated","total_value":77713.3766,"total_display":"77,713.38","shares_owned_after":5633.0,"shares_owned_after_display":"5,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-09","filed_date":"2024-05-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Director","n_filings":2,"first_seen":"2024-05-17","last_seen":"2025-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001714949","retrieved_at":"2026-08-21T04:13:29+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}